Published in:
01-03-2018 | COMMENTARY
Human papillomavirus vaccine: Urgent need to promote gender parity
Published in: European Journal of Epidemiology | Issue 3/2018
Login to get accessExcerpt
In this issue of the Journal, Shield et al. [1] outline the leading role of human papillomavirus (HPV) in human cancers by identifying it as the leading infectious cause of cancers in France in 2015 with 6333 of the 352,000 new cancer cases identified over this year at the national level attributable to HPV [4580 new cancers in women (72.3% of the total) and 1753 new cancer cases in males (27.7% of the total)]. They reported that the three most prevalent HPV-attributable cancers in France were cervical cancers (2917 new cancer cases) followed by anal cancers (1458 new cancer cases) and oropharyngeal cancers (1371 new cancer cases) (Table 1) [1].
Table 1
Worldwide (2012), Europe (2012) and national (2015) estimates of the number of new cancer cases attributable to Human papillomavirus (HPV)
|
HPV-related cancer site
|
Worlda
|
Europea,b
|
Francec
|
||||||
|---|---|---|---|---|---|---|---|---|---|
|
All
|
Males
|
Females
|
All
|
Males
|
Females
|
All
|
Males
|
Females
|
|
|
Cervical cancers
|
530,000
|
0
|
530,000
|
58,000
|
0
|
58,000
|
2917
|
0
|
2917
|
|
Anal cancers
|
35,000
|
17,000
|
18,000
|
6900
|
2700
|
4200
|
1458
|
360
|
1098
|
|
Vulvar and vaginal cancers
|
20,500
|
0
|
20,500
|
5100
|
0
|
5100
|
187
|
0
|
187
|
|
Oropharyngeal cancers
|
29,000
|
24,000
|
5000
|
13,800
|
11,000
|
2800
|
1371
|
1059
|
312
|
|
Oral cavity cancers
|
4400
|
2900
|
1500
|
173
|
123
|
50
|
|||
|
Laryngeal cancers
|
3800
|
3300
|
500
|
138
|
121
|
17
|
|||
|
Penile cancers
|
13,000
|
13,000
|
0
|
2700
|
2700
|
0
|
90
|
90
|
0
|
|
Total
|
630,000
|
60,200
|
569,800
|
86,500
|
16,400
|
70,100
|
6333
|
1753
|
4580
|